These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2572554)
1. Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally. Ogawa T; Shimauchi H; Hamada S Infect Immun; 1989 Nov; 57(11):3466-71. PubMed ID: 2572554 [TBL] [Abstract][Full Text] [Related]
2. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice]. Shimauchi H Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739 [TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to Bacteroides gingivalis fimbrial antigen in mice. Ogawa T; Shimauchi H; Kusumoto Y; Hamada S Immunology; 1990 Jan; 69(1):8-13. PubMed ID: 1968885 [TBL] [Abstract][Full Text] [Related]
4. Generation of specific antibody-secreting cells in salivary glands of BALB/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae. Kusumoto Y; Ogawa T; Hamada S Arch Oral Biol; 1993 May; 38(5):361-7. PubMed ID: 8101076 [TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune responses to the fimbriae of Porphyromonas gingivalis and their synthetic peptides. Ogawa T; Ogo H; Uchida H; Hamada S J Med Microbiol; 1994 Jun; 40(6):397-402. PubMed ID: 7911839 [TBL] [Abstract][Full Text] [Related]
6. Occurrence of antigen-specific B cells following oral or parenteral immunization with Porphyromonas gingivalis fimbriae. Ogawa T; Kusumoto Y; Kiyono H; McGhee JR; Hamada S Int Immunol; 1992 Sep; 4(9):1003-10. PubMed ID: 1356427 [TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal and serum immune responses to a specific antigen of periodontal bacteria. Hamada S; Ogawa T; Shimauchi H; Kusumoto Y Adv Exp Med Biol; 1992; 327():71-81. PubMed ID: 1284188 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin. Ogawa T; Kotani S; Shimauchi H Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542 [TBL] [Abstract][Full Text] [Related]
9. Bacteroides gingivalis-specific serum IgG and IgA subclass antibodies in periodontal diseases. Ogawa T; Kusumoto Y; Hamada S; McGhee JR; Kiyono H Clin Exp Immunol; 1990 Nov; 82(2):318-25. PubMed ID: 1978704 [TBL] [Abstract][Full Text] [Related]
10. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339 [TBL] [Abstract][Full Text] [Related]
11. Oral administration of Porphyromonas gingivalis fimbriae with cholera toxin induces anti-fimbriae serum IgG, IgM, IgA and salivary IgA antibodies. Nagasawa T; Aramaki M; Takamatsu N; Koseki T; Kobayashi H; Ishikawa I J Periodontal Res; 1999 Apr; 34(3):169-74. PubMed ID: 10384405 [No Abstract] [Full Text] [Related]
12. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Ogawa T; Kotani S; Shimauchi H Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372 [TBL] [Abstract][Full Text] [Related]
13. Fimbria-specific antibodies in serum and saliva of mice immunized with Actinomyces viscosus T14V fimbriae. Crawford PC; Clark WB Infect Immun; 1986 Nov; 54(2):507-15. PubMed ID: 2876962 [TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva. Ogawa T; Kono Y; McGhee ML; McGhee JR; Roberts JE; Hamada S; Kiyono H Clin Exp Immunol; 1991 Feb; 83(2):237-44. PubMed ID: 1671564 [TBL] [Abstract][Full Text] [Related]
16. Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice. Kawabata S; Terao Y; Fujiwara T; Nakagawa I; Hamada S Infect Immun; 1999 Nov; 67(11):5863-8. PubMed ID: 10531241 [TBL] [Abstract][Full Text] [Related]
17. Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice. Strindelius L; Folkesson A; Normark S; Sjöholm I Vaccine; 2004 Mar; 22(11-12):1448-56. PubMed ID: 15063568 [TBL] [Abstract][Full Text] [Related]
18. Immune response gene regulation of the humoral immune response to Porphyromonas gingivalis fimbriae in mice. Shimauchi H; Ogawa T; Hamada S Immunology; 1991 Oct; 74(2):362-4. PubMed ID: 1684172 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447 [TBL] [Abstract][Full Text] [Related]
20. Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants. Morisaki I; Michalek SM; Harmon CC; Torii M; Hamada S; McGhee JR Infect Immun; 1983 May; 40(2):577-91. PubMed ID: 6840853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]